4.7 Article

A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 144, Issue 2, Pages 231-241

Publisher

WILEY
DOI: 10.1038/sj.bjp.0706071

Keywords

MDMA; HHMA; 5-HT; dopamine; temperature; intrastriatal administration; mice; MDMA metabolism; neurotoxicity

Ask authors/readers for more resources

1 This study investigated whether the immediate and long-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in mouse brain are due to the parent compound and the possible contribution of a major reactive metabolite, 3,4-dihydroxymethamphetamine (HHMA), to these changes. The acute effect of each compound on rectal temperature was also determined. 2 MDMA given i.p. (30 mg kg(-1), three times at 3-h intervals), but not into the striatum (1, 10 and 100 mg, three times at 3-h intervals), produced a reduction in striatal dopamine content and modest 5-HT reduction 1 h after the last dose. MDMA does not therefore appear to be responsible for the acute monoamine release that follows its peripheral injection. 3 HHMA does not contribute to the acute MDMA-induced dopamine depletion as the acute central effects of MDMA and HHMA differed following i.p. injection. Both compounds induced hyperthermia, confirming that the acute dopamine depletion is not responsible for the temperature changes. 4 Peripheral administration of MDMA produced dopamine depletion 7 days later. Intrastriatal MDMA administration only produced a long-term loss of dopamine at much higher concentrations than those reached after the i.p. dose and therefore bears little relevance to the neurotoxicity. This indicates that the long-term effect is not attributable to the parent compound. HHMA also appeared not to be responsible as i.p. administration failed to alter the striatal dopamine concentration 7 days later. 5 HHMA was detected in plasma, but not in brain, following MDMA ( i.p.), but it can cross the blood - brain barrier as it was detected in the brain following its peripheral injection. 6 The fact that the acute changes induced by i.p. or intrastriatal HHMA administration differed indicates that HHMA is metabolised to other compounds which are responsible for changes observed after i.p. administration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Addiction and the kynurenine pathway: A new dancing couple?

Nuria Morales-Puerto, Pablo Gimenez-Gomez, Mercedes Perez-Hernandez, Cristina Abuin-Martinez, Leticia Gil de Biedma-Elduayen, Rebeca Vidal, Maria Dolores Gutierrez-Lopez, Esther O'Shea, Maria Isabel Colado

Summary: Drug use poses a serious threat to health systems worldwide, with the kynurenine pathway being of interest in relation to addictive behavior. Recent studies suggest that modulation of certain stages of this pathway can reduce, prevent, or abolish drug seeking-like behaviors.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Neurosciences

Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor

C. Abuin-Martinez, R. Vidal, M. D. Gutierrez-Lopez, M. Perez-Hernandez, P. Gimenez-Gomez, N. Morales-Puerto, E. O'Shea, M. I. Colado

Summary: The study revealed that MDMA induces serotonergic neurotoxicity by activating the KYN pathway and AhR in rats. Modulation of these pathways could serve as potential therapeutic strategies to limit the negative effects of MDMA-induced brain damage.

NEUROPHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice

Leticia Gil de Biedma-Elduayen, Pablo Gimenez-Gomez, Nuria Morales-Puerto, Rebeca Vidal, Carlos Nunez-de la Calle, Maria Dolores Gutierrez-Lopez, Esther O'Shea, Maria Isabel Colado

Summary: Inhibition of kynurenine 3-monooxygenase reduces ethanol consumption and preference in male and female mice, which is mediated by alpha 7nAChR. Moreover, this effect can be prolonged by blocking the efflux of peripheral kynurenine to the brain, providing an effective strategy for the treatment of ethanol dependence.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Chemistry, Analytical

Determination of up to twenty carboxylic acid containing compounds in clinically relevant matrices by o-benzylhydroxylamine derivatization and liquid chromatography-tandem mass spectrometry.

Alex Gomez-Gomez, Eulalia Olesti, Blanca Montero-San-Martin, Angie Soldevila, Tessa Deschamps, Nieves Pizarro, Rafael de la Torre, Oscar J. Pozo

Summary: A LC-MS/MS method for the quantification of 20 endogenous R-COOH in different pathways was developed and optimized. The method was applied in various matrices and proved suitable for studying R-COOH status in health and disease through targeted metabolomics. Adequate accuracy and precision were achieved, making this methodology a valuable tool for biochemical research.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Article Biochemistry & Molecular Biology

Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency

Marta Moya, Leticia Lopez-Valencia, Borja Garcia-Bueno, Laura Orio

Summary: Wernicke-Korsakoff syndrome is caused by thiamine deficiency and alcohol consumption, mainly affecting frontal cortex function. This study using a rat model confirms the significant impact of the interaction between alcohol and TD on neuronal damage.

BIOMEDICINES (2022)

Article Medicine, Research & Experimental

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience

Francisco Madrid-Gambin, Alex Gomez-Gomez, Arnau Busquets-Garcia, Noemi Haro, Santiago Marco, Natasha L. Mason, Johannes T. Reckweg, Pablo Mallaroni, Lilian Kloft, Kim van Oorsouw, Stefan W. Toennes, Rafael de la Torre, Johannes G. Ramaekers, Kin Van Oorsouw, Stefan W. Toennes, Rafael De la Torre, Johannes G. Ramaekers, Oscar J. Pozo

Summary: This study investigates the human metabolomics signature after consuming the psychedelic ayahuasca and its connection to subjective effects and plasma concentrations of ayahuasca alkaloids. The results suggest a crosstalk between circulating large-neutral amino acids and subjective effects, independent of alkaloid concentrations. Dysregulation in neurotransmission pathways such as serotonin and dopamine synthesis is also observed.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Multidisciplinary Sciences

Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation

Teresa Oliveras, Iolanda Lazaro, Ferran Rueda, German Cediel, Deepak L. Bhatt, Montserrat Fito, Francisco Madrid-Gambin, Oscar J. Pozo, William S. Harris, Cosme Garcia-Garcia, Aleix Sala-Vila, Antoni Bayes-Genis

Summary: This study found that levels of linoleic acid (LA) in serum phospholipids are associated with susceptibility to primary ventricular fibrillation (PVF). PVF patients had lower levels of LA. Each one standard deviation increase in the proportion of LA was associated with a 42% lower prevalence of PVF.

SCIENTIFIC REPORTS (2022)

Article Neurosciences

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

Maria Flores-Lopez, Nuria Garcia-Marchena, Pedro Araos, Nerea Requena-Ocana, Oscar Porras-Perales, Sandra Torres-Galvan, Juan Suarez, Nieves Pizarro, Rafael de la Torre, Gabriel Rubio, Juan Jesus Ruiz-Ruiz, Fernando Rodriguez de Fonseca, Antonia Serrano, Francisco Javier Pavon-Moron

Summary: The study investigated the concentrations of LPA in patients with substance use disorder, finding that women had higher LPA concentrations than men and SUD patients had lower LPA concentrations. LPA species could potentially serve as biomarkers for SUD in both women and men.

BRAIN SCIENCES (2022)

Letter Clinical Neurology

A case of Wernicke's encephalopathy that maintains long-term cognitive deterioration but not inflammation in spite of thiamine supplementation

Laura Orio, Francisco Arias, Berta Escudero

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

Article Medicine, General & Internal

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

Giulia Testa, Lucia Camacho-Barcia, Carlos Gomez-Martinez, Bernat Mora-Maltas, Rafael de la Torre, Xavier Pinto, Dolores Corella, Roser Granero, Aida Cuenca-Royo, Susana Jimenez-Murcia, Nancy Babio, Rebeca Fernandez-Carrion, Virginia Esteve-Luque, Laura Forcano, Jiaqi Ni, Mireia Malcampo, Sara De las Heras-Delgado, Montse Fito, Jordi Salas-Salvado, Fernando Fernandez-Aranda

Summary: The study found that impulsivity traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Pharmacology & Pharmacy

Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice

Miguel A. A. Olivencia, Leticia Gil de Biedma-Elduayen, Pablo Gimenez-Gomez, Bianca Barreira, Argentina Fernandez, Javier Angulo, Maria Isabel Colado, Esther O'Shea, Francisco Perez-Vizcaino

Summary: This study investigates the relationship between alcohol abuse and erectile dysfunction (ED), finding that alterations in soluble guanylyl cyclase (sGC) may contribute to ED caused by alcoholism. The results show that alcohol abuse reduces the relaxant response of the corpora cavernosa (CC) but enhances the response to sGC activators, while also increasing reactive oxygen species and protein expression of CYP2E1 and NOX2. These findings suggest that sGC activators may be effective in treating ED associated with alcoholism.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Clinical Neurology

Reelin Plasma Levels Identify Cognitive Decline in Alcohol Use Disorder Patients During Early Abstinence: The Influence of APOE4 Expression

Berta Escudero, Marta Moya, Leticia Lopez-Valencia, Francisco Arias, Laura Orio

Summary: This study investigated the expression of APOE4 and reelin, as well as cognitive function, in patients with alcohol use disorder (AUD) and controls. The results showed that APOE4 expression levels were similar between patients and controls, but levels of clusterin and reelin were higher in patients with AUD. Multivariate logistic regression analysis identified reelin as a good indicator of cognitive impairment in early abstinence. During a 6-month abstinence period, reelin levels decreased in patients with AUD and cognitive function improved.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

The role of PPAR-gamma in memory deficits induced by prenatal and lactation alcohol exposure in mice

Alba Garcia-Baos, Antoni Pastor, Ines Gallego-Landin, Rafael de la Torre, Ferran Sanz, Olga Valverde

Summary: Patients with Fetal Alcohol Spectrum Disorder (FASD) exhibit long-lasting cognitive disabilities, including memory deficits, but the underlying neurobiological mechanisms are not clear. By studying alcohol-exposed mice, researchers found that prenatal and lactation alcohol exposure induces FASD-like memory impairments through the reduction of N-acylethanolamines (NAEs) and peroxisome proliferator-activated receptor gamma (PPAR-gamma) in the hippocampus during a childhood-like period. Pharmacological interventions targeting NAEs and PPAR-gamma were able to improve memory deficits, and overexpression of PPAR-gamma in hippocampal astrocytes mitigated memory impairments induced by alcohol exposure.

MOLECULAR PSYCHIATRY (2023)

Review Biochemistry & Molecular Biology

Olive Oil Phenolic Compounds' Activity against Age-Associated Cognitive Decline: Clinical and Experimental Evidence

Anna Boronat, Gabriele Serreli, Jose Rodriguez-Morato, Monica Deiana, Rafael de la Torre

Summary: Epidemiological studies suggest that consuming olive oil rich in phenolic bioactive compounds may lower the risk of neurodegenerative diseases and improve cognitive performance in the elderly. Preclinical evidence indicates that olive oil phenolic compounds can counteract oxidative stress and neuroinflammation, key processes in neurodegeneration. Clinical evidence suggests that high consumption of olive oil phenolic compounds is associated with better cognitive preservation, independent of dietary patterns. Further research is needed to understand the mechanisms and potential clinical applications.

ANTIOXIDANTS (2023)

Article Clinical Neurology

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Bjoern Schurad, Cornelius Koch, Barbara Schug, Adelaida Morte, Anna Vaque, Rafael De la Torre, Marc Iniesta

Summary: This study assessed the bioequivalence of a multi-day rivastigmine transdermal patch (RID-TDS) compared to a once-daily Exelon (R) transdermal patch. Both patches had a release rate of 9.5 mg/24 h. The results showed that RID-TDS and Exelon (R) were bioequivalent, with satisfactory adhesion demonstrated for RID-TDS. The findings suggest that the multi-day patch may offer greater convenience for patients' therapeutic management.

CURRENT ALZHEIMER RESEARCH (2022)

No Data Available